Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Consolidated Net Income (2019 - 2025)

Historic Consolidated Net Income for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to -$18.1 million.

  • Korro Bio's Consolidated Net Income rose 1399.11% to -$18.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$88.5 million, marking a year-over-year decrease of 76.19%. This contributed to the annual value of -$83.6 million for FY2024, which is 304.17% down from last year.
  • Korro Bio's Consolidated Net Income amounted to -$18.1 million in Q3 2025, which was up 1399.11% from -$25.8 million recorded in Q2 2025.
  • Over the past 5 years, Korro Bio's Consolidated Net Income peaked at $6.2 million during Q4 2022, and registered a low of -$25.8 million during Q2 2025.
  • Over the past 5 years, Korro Bio's median Consolidated Net Income value was -$21.0 million (recorded in 2024), while the average stood at -$19.7 million.
  • In the last 5 years, Korro Bio's Consolidated Net Income soared by 12877.21% in 2022 and then crashed by 51102.49% in 2023.
  • Korro Bio's Consolidated Net Income (Quarter) stood at -$21.5 million in 2021, then skyrocketed by 128.77% to $6.2 million in 2022, then tumbled by 511.02% to -$25.4 million in 2023, then rose by 16.39% to -$21.3 million in 2024, then increased by 15.04% to -$18.1 million in 2025.
  • Its Consolidated Net Income stands at -$18.1 million for Q3 2025, versus -$25.8 million for Q2 2025 and -$23.4 million for Q1 2025.